Leptin signaling

F1000Prime Reports

Volumn 6, Issue , 2014, Pages

  Park, Hyeong Kyu ^a   Ahima, Rexford S ^b  

^a Soonchunhyang University College of Medicine   (South Korea)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' ADENOSINE MONOPHOSPHATE ACTIVATED PROTEIN KINASE; ACETYL COENZYME A CARBOXYLASE; GLUCOSE; INSULIN RECEPTOR SUBSTRATE; JANUS KINASE 2; LEPTIN; LEPTIN RECEPTOR; LIPID; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE; PROTEIN TYROSINE PHOSPHATASE SHP 2; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ADIPOSE TISSUE; CENTRAL NERVOUS SYSTEM; ENERGY HOMEOSTASIS; ENERGY METABOLISM; ENZYME ACTIVATION; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HORMONE RECEPTOR INTERACTION; HORMONE RELEASE; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LIPID METABOLISM; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; REGULATORY MECHANISM; REVIEW;

EID: 84907044387     PISSN: 20517599     EISSN: 20517599     Source Type: Journal    
DOI: 10.12703/P6-73     Document Type: Review

References (67)

1. Dardeno TA, Chou SH, Moon H, Chamberland JP, Fiorenza CG, Mantzoros CS: Leptin in human physiology and therapeutics. Front Neuroendocrinol 2010, 31:377-93.
2. Dalamaga M, Chou SH, Shields K, Papageorgiou P, Polyzos SA, Mantzoros CS: Leptin at the intersection of neuroendocrinology and metabolism: current evidence and therapeutic perspectives. Cell Metab 2013, 18:29-42.
3. Moon H, Dalamaga M, Kim S, Polyzos SA, Hamnvik O, Magkos F, Paruthi J, Mantzoros CS: Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals. Endocr Rev 2013, 34:377-412.
4. Ahima RS, Osei SY: Leptin signaling. Physiol Behav 2004, 81:223-41.
5. Kelesidis T, Kelesidis I, Chou S, Mantzoros CS: Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med 2010, 152:93-100.
6. Myers MG, Heymsfield SB, Haft C, Kahn BB, Laughlin M, Leibel RL, Tschöp MH, Yanovski JA: Challenges and opportunities of defining clinical leptin resistance. Cell Metab 2012, 15:150-6.
7. Jung CH, Kim M: Molecular mechanisms of central leptin resistance in obesity. Arch Pharm Res 2013, 36:201-7.
8. Xu Y, Elmquist JK, Fukuda M: Central nervous control of energy and glucose balance: focus on the central melanocortin system. Ann N Y Acad Sci 2011, 1243:1-14.
9. Morris DL, Rui L: Recent advances in understanding leptin signaling and leptin resistance. Am J Physiol Endocrinol Metab 2009, 297:E1247-59.
10. Kim KW, Sohn J, Kohno D, Xu Y, Williams K, Elmquist JK: SF-1 in the ventral medial hypothalamic nucleus: a key regulator of homeostasis. Mol Cell Endocrinol 2011, 336:219-23.
11. Jiang L, You J, Yu X, Gonzalez L, Yu Y, Wang Q, Yang G, Li W, Li C, Liu Y: Tyrosine-dependent and -independent actions of leptin receptor in control of energy balance and glucose homeostasis. Proc Natl Acad Sci U S A 2008, 105:18619-24.
12. Gao Q, Wolfgang MJ, Neschen S, Morino K, Horvath TL, Shulman GI, Fu X: Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation. Proc Natl Acad Sci U S A 2004, 101:4661-6.
13. Bates SH, Stearns WH, Dundon TA, Schubert M, Tso, Annette WK, Wang Y, Banks AS, Lavery HJ, Haq AK, Maratos-Flier E, Neel BG, Schwartz MW, Myers MG: STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature 2003, 421:856-9.
14. Piper ML, Unger EK, Myers MG, Xu AW: Specific physiological roles for signal transducer and activator of transcription 3 in leptin receptor-expressing neurons. Mol Endocrinol 2008, 22:751-9.
15. Lee J, Muenzberg H, Gavrilova O, Reed JA, Berryman D, Villanueva EC, Louis GW, Leinninger GM, Bertuzzi S, Seeley RJ, Robinson GW, Myers MG, Hennighausen L: Loss of cytokine-STAT5 signaling in the CNS and pituitary gland alters energy balance and leads to obesity. PLoS ONE 2008, 3:e1639.
16. Belgardt BF, Brüning JC: CNS leptin and insulin action in the control of energy homeostasis. Ann N Y Acad Sci 2010, 1212:97-113.
17. Könner AC, Brüning JC: Selective insulin and leptin resistance in metabolic disorders. Cell Metab 2012, 16:144-52.
18. Varela L, Horvath TL: Leptin and insulin pathways in POMC and AgRP neurons that modulate energy balance and glucose homeostasis. EMBO Rep 2012, 13:1079-86.
19. Elias CF, Purohit D: Leptin signaling and circuits in puberty and fertility. Cell Mol Life Sci 2013, 70:841-62.
20. Niswender KD, Morton GJ, Stearns WH, Rhodes CJ, Myers MG, Schwartz MW: Intracellular signalling. Key enzyme in leptin-induced anorexia. Nature 2001, 413:794-5.
21. Hill JW, Williams KW, Ye C, Luo J, Balthasar N, Coppari R, Cowley MA, Cantley LC, Lowell BB, Elmquist JK: Acute effects of leptin require PI3K signaling in hypothalamic proopiomelanocortin neurons in mice. J Clin Invest 2008, 118:1796-805.
22. Kim M, Pak YK, Jang P, Namkoong C, Choi Y, Won J, Kim K, Kim S, Kim H, Park J, Kim Y, Lee K: Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis. Nat Neurosci 2006, 9:901-6.
23. Morrison CD, Morton GJ, Niswender KD, Gelling RW, Schwartz MW: Leptin inhibits hypothalamic Npy and Agrp gene expression via a mechanism that requires phosphatidylinositol 3-OH-kinase signaling. Am J Physiol Endocrinol Metab 2005, 289:E1051-7.
24. Kitamura T, Feng Y, Kitamura YI, Chua SC, Xu AW, Barsh GS, Rossetti L, Accili D: Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake. Nat Med 2006, 12:534-40.
25. Plum L, Lin HV, Dutia R, Tanaka J, Aizawa KS, Matsumoto M, Kim AJ, Cawley NX, Paik J, Loh YP, DePinho RA, Wardlaw SL, Accili D: The obesity susceptibility gene Cpe links FoxO1 signaling in hypothalamic pro-opiomelanocortin neurons with regulation of food intake. Nat Med 2009, 15:1195-201.
26. Ren H, Orozco IJ, Su Y, Suyama S, Gutiérrez-Juárez R, Horvath TL, Wardlaw SL, Plum L, Arancio O, Accili D: FoxO1 target Gpr17 activates AgRP neurons to regulate food intake. Cell 2012, 149:1314-26.
27. Cota D, Proulx K, Smith, Kathi A Blake, Kozma SC, Thomas G, Woods SC, Seeley RJ: Hypothalamic mTOR signaling regulates food intake. Science 2006, 312:927-30.
28. Cota D, Matter EK,Woods SC, Seeley RJ: The role of hypothalamic mammalian target of rapamycin complex 1 signaling in diet-induced obesity. J Neurosci 2008, 28:7202-8.
29. Blouet C, Ono H, Schwartz GJ: Mediobasal hypothalamic p70 S6 kinase 1 modulates the control of energy homeostasis. Cell Metab 2008, 8:459-67.
30. Zhao AZ, Huan J, Gupta S, Pal R, Sahu A: A phosphatidylinositol 3-kinase phosphodiesterase 3B-cyclic AMP pathway in hypothalamic action of leptin on feeding. Nat Neurosci 2002, 5:727-8.
31. Sahu A: Intracellular leptin-signaling pathways in hypothalamic neurons: the emerging role of phosphatidylinositol-3 kinase-phosphodiesterase-3B-cAMP pathway. Neuroendocrinology 2011, 93:201-10.
32. Rahmouni K, Haynes WG, Morgan DA, Mark AL: Intracellular mechanisms involved in leptin regulation of sympathetic outflow. Hypertension 2003, 41:763-7.
33. Zhang EE, Chapeau E, Hagihara K, Feng G: Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism. Proc Natl Acad Sci U S A 2004, 101:16064-9.
34. Rahmouni K, Sigmund CD, Haynes WG, Mark AL: Hypothalamic ERK mediates the anorectic and thermogenic sympathetic effects of leptin. Diabetes 2009, 58:536-42.
35. Minokoshi Y, Alquier T, Furukawa N, Kim Y, Lee A, Xue B, Mu J, Foufelle F, Ferré P, Birnbaum MJ, Stuck BJ, Kahn BB: AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 2004, 428:569-74.
36. Gao S, Kinzig KP, Aja S, Scott KA, Keung W, Kelly S, Strynadka K, Chohnan S, Smith WW, Tamashiro, Kellie LK, Ladenheim EE, Ronnett GV, Tu Y, Birnbaum MJ, Lopaschuk GD, Moran TH: Leptin activates hypothalamic acetyl-CoA carboxylase to inhibit food intake. Proc Natl Acad Sci U S A 2007, 104:17358-63.
37. Dagon Y, Hur E, Zheng B, Wellenstein K, Cantley LC, Kahn BB: p70S6 kinase phosphorylates AMPK on serine 491 to mediate leptin's effect on food intake. Cell Metab 2012, 16:104-12.
38. Coppari R, Bjørbæk C: Leptin revisited: its mechanism of action and potential for treating diabetes. Nat Rev Drug Discov 2012, 11:692-708.
39. Coppari R, Ichinose M, Lee CE, Pullen AE, Kenny CD, McGovern RA, Tang V, Liu SM, Ludwig T, Chua SC, Lowell BB, Elmquist JK: The hypothalamic arcuate nucleus: a key site for mediating leptin's effects on glucose homeostasis and locomotor activity. Cell Metab 2005, 1:63-72.
40. Huo L, Gamber K, Greeley S, Silva J, Huntoon N, Leng X, Bjørbaek C: Leptin-dependent control of glucose balance and locomotor activity by POMC neurons. Cell Metab 2009, 9:537-47.
41. Kievit P, Howard JK, Badman MK, Balthasar N, Coppari R, Mori H, Lee CE, Elmquist JK, Yoshimura A, Flier JS: Enhanced leptin sensitivity and improved glucose homeostasis in mice lacking suppressor of cytokine signaling-3 in POMC-expressing cells. Cell Metab 2006, 4:123-32.
42. Banno R, Zimmer D, De Jonghe, Bart C, Atienza M, Rak K, Yang W, Bence KK: PTP1B and SHP2 in POMC neurons reciprocally regulate energy balance in mice. J Clin Invest 2010, 120:720-34.
43. Ibrahim N, Bosch MA, Smart JL, Qiu J, Rubinstein M, Rønnekleiv OK, Low MJ, Kelly MJ: Hypothalamic proopiomelanocortin neurons are glucose responsive and express K(ATP) channels. Endocrinology 2003, 144:1331-40.
44. Kim KW, Donato J, Berglund ED, Choi Y, Kohno D, Elias CF, DePinho RA, Elmquist JK: FOXO1 in the ventromedial hypothalamus regulates energy balance. J Clin Invest 2012, 122:2578-89.
45. Hill JW, Xu Y, Preitner F, Fukuda M, Cho Y, Luo J, Balthasar N, Coppari R, Cantley LC, Kahn BB, Zhao JJ, Elmquist JK: Phosphatidyl inositol 3-kinase signaling in hypothalamic proopiomelanocortin neurons contributes to the regulation of glucose homeostasis. Endocrinology 2009, 150:4874-82.
46. Buettner C, Muse ED, Cheng A, Chen L, Scherer T, Pocai A, Su K, Cheng B, Li X, Harvey-White J, Schwartz GJ, Kunos G, Rossetti L: Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms. Nat Med 2008, 14:667-75.
47. Scherer T, Buettner C: Yin and Yang of hypothalamic insulin and leptin signaling in regulating white adipose tissue metabolism. Rev Endocr Metab Disord 2011, 12:235-43.
48. Roman, Erika AFR, Reis D, Romanatto T, Maimoni D, Ferreira EA, Santos GA, Torsoni AS, Velloso LA, Torsoni MA: Central leptin action improves skeletal muscle AKT, AMPK, and PGC1 alpha activation by hypothalamic PI3K-dependent mechanism. Mol Cell Endocrinol 2010, 314:62-9.
49. Donato J, Frazão R, Elias CF: The PI3K signaling pathway mediates the biological effects of leptin. Arq Bras Endocrinol Metabol 2010, 54:591-602.
50. Minokoshi Y, Kim Y, Peroni OD, Fryer, Lee GD, Müller C, Carling D, Kahn BB: Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 2002, 415:339-43.
51. Sharma V, Mustafa S, Patel N, Wambolt R, Allard MF, McNeill JH: Stimulation of cardiac fatty acid oxidation by leptin is mediated by a nitric oxide-p38 MAPK-dependent mechanism. Eur J Pharmacol 2009, 617:113-7.
52. German JP, Thaler JP, Wisse BE, Oh-I S, Sarruf DA, Matsen ME, Fischer JD, Taborsky GJ, Schwartz MW, Morton GJ: Leptin activates a novel CNS mechanism for insulin-independent normalization of severe diabetic hyperglycemia. Endocrinology 2011, 152:394-404.
53. Berglund ED, Vianna CR, Donato J, Kim MH, Chuang J, Lee CE, Lauzon DA, Lin P, Brule LJ, Scott MM, Coppari R, Elmquist JK: Direct leptin action on POMC neurons regulates glucose homeostasis and hepatic insulin sensitivity in mice. J Clin Invest 2012, 122:1000-9.
54. Zhao AZ, Shinohara MM, Huang D, Shimizu M, Eldar-Finkelman H, Krebs EG, Beavo JA, Bornfeldt KE: Leptin induces insulin-like signaling that antagonizes cAMP elevation by glucagon in hepatocytes. J Biol Chem 2000, 275:11348-54.
55. Marroquí L, Gonzalez A, Ñeco P, Caballero-Garrido E, Vieira E, Ripoll C, Nadal A, Quesada I: Role of leptin in the pancreatic β-cell: effects and signaling pathways. J Mol Endocrinol 2012, 49: R9-17.
56. Laubner K, Kieffer TJ, Lam NT, Niu X, Jakob F, Seufert J: Inhibition of preproinsulin gene expression by leptin induction of suppressor of cytokine signaling 3 in pancreatic beta-cells. Diabetes 2005, 54:3410-7.
57. Lee Y, Magkos F, Mantzoros CS, Kang ES: Effects of leptin and adiponectin on pancreatic β-cell function. Metab Clin Exp 2011, 60:1664-72.
58. Carbone F, La Rocca C, Matarese G: Immunological functions of leptin and adiponectin. Biochimie 2012, 94:2082-8.
59. Paz-Filho G, Mastronardi C, Franco CB, Wang KB, Wong M, Licinio J: Leptin: molecular mechanisms, systemic pro-inflammatory effects, and clinical implications. Arq Bras Endocrinol Metabol 2012, 56:597-607.
60. Bruno A, Conus S, Schmid I, Simon H: Apoptotic pathways are inhibited by leptin receptor activation in neutrophils. J Immunol 2005, 174:8090-6.
61. Lam, Queenie Lai Kwan, Zheng B, Jin D, Cao X, Lu L: Leptin induces CD40 expression through the activation of Akt in murine dendritic cells. J Biol Chem 2007, 282:27587-97.
62. Zhao Y, Sun R, You L, Gao C, Tian Z: Expression of leptin receptors and response to leptin stimulation of human natural killer cell lines. Biochem Biophys Res Commun 2003, 300:247-52.
63. Iikuni N, Lam, Queenie Lai Kwan, Lu L, Matarese G, La Cava A: Leptin and Inflammation. Curr Immunol Rev 2008, 4:70-9.
64. Procaccini C, Jirillo E, Matarese G: Leptin as an immunomodulator. Mol Aspects Med 2012, 33:35-45.
65. Rosa V de, Procaccini C, Calì G, Pirozzi G, Fontana S, Zappacosta S, La Cava A, Matarese G: A key role of leptin in the control of regulatory T cell proliferation. Immunity 2007, 26:241-55.
66. Procaccini C, Rosa V de, Galgani M, Abanni L, Calì G, Porcellini A, Carbone F, Fontana S, Horvath TL, La Cava A, Matarese G: An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness. Immunity 2010, 33:929-41.
67. Agrawal S, Gollapudi S, Su H, Gupta S: Leptin activates human B cells to secrete TNF-α, IL-6, and IL-10 via JAK2/STAT3 and p38MAPK/ERK1/2 signaling pathway. J Clin Immunol 2011, 31:472-8.